- Clinical Assistant Professor, CWRU School of Medicine
Dr. Maroun Matta graduated from St. Joseph University School of Medicine in Beirut, Lebanon in 2010. He completed a residency in internal medicine and fellowship in Pulmonary and Critical Care at University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine in Cleveland.
He then joined the clinical staff at UH Cleveland Medical Center, currently serving as the co-director for advanced lung diseases, and program director for pulmonary and critical care fellowship training. He has also received a master’s degree in clinical and translational research through Case Western Reserve University, and is an assistant professor in the School of Medicine.
Dr. Matta’s clinical interests are interstitial lung disease (ILD), lung transplantation and medical education. He has been an investigator on multiple idiopathic pulmonary fibrosis (IPF) clinical trials. In the lab, he studies nitric oxide bio-availability and its impact on organ function for transplantation. Dr. Matta continues to focus on the multidisciplinary approach to the diagnosis and treatment of advanced pulmonary disease and ILD.
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung Diseases
- Lung Transplantation
- Pulmonary Hypertension
English, Arabic, French
- Critical Care Medicine - American Board of Internal Medicine
- Pulmonary Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Pulmonary/Critical Care
Pulmonary/Critical Care - Uh Case Medical Center (2013 - 2016)
Residency | Internal Medicine
Internal Medicine - Uh Case Medical Center (2010 - 2013)
Universite St Joseph, Faculty Of Medicine (2010)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Maroun Matta did not disclose any Outside Relationships with Industry.